Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2017. 25 of 27 entries say "Materialised", first in FY2018-Q1. Latest entry: FY2026.
Chikaranomoto Holdings moved to the "Worse" side of this theme in 2017, 3 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「1 April 2025–31 March 2026 (Note) 1 10,000 30,318,000 1,325 3,149,715 1,325 3,050,514 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, 10,000 shares were added through the exercise of stock acquisition rights, bringing the total number of shares issued and outstanding to 30,318,000. - FY2025MaterialisedAnnual report
「1 April 2024–31 March 2025 (Note) 1 55,000 30,308,000 7,287 3,148,390 7,287 3,049,189 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, 55,000 shares were added through the exercise of stock acquisition rights, bringing the total number of shares issued and outstanding to 30,308,000. - FY2024MaterialisedAnnual report
「1 April 2023–31 March 2024 (Note) 1, 3 177,600 30,253,000 23,532 3,141,103 23,532 3,041,902」
During the fiscal year, 177,600 shares were added through the exercise of stock acquisition rights, with dilution continuing to materialize as actual share issuance. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 29,000 30,134,400 3,842 3,125,388 3,842 3,026,187 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 29,000 shares were added through the exercise of stock acquisition rights, bringing the total number of shares issued and outstanding to 30,134,400. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 30,000 30,105,400 3,975 3,121,546 3,975 3,022,345 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 30,000 shares were added through the exercise of stock acquisition rights, bringing the total number of shares issued and outstanding to 30,105,400. - FY2023MaterialisedAnnual report
「1 April 2022–31 March 2023 (Note) 1, 3,033,000, 30,075,400, 977,737, 3,117,571, 974,536, 3,018,370 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year ended March 2023, 3,033,000 shares were added through the exercise of stock acquisition rights, bringing the total number of shares issued and outstanding to 30,075,400. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 1,279,000 30,063,400 464,112 3,115,981 462,459 3,016,780 (Note) Between 1 October 2022 and 31 December 2022, the exercise of stock acquisition rights increased the total number of shares issued and outstanding by 1,279,000 shares, capital by ¥464,112 thousand and the capital reserve by ¥462,459 thousand.」
During the third quarter, 1,279,000 shares were added through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 836,000 28,784,400 244,840 2,651,868 244,102 2,554,320 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 836,000 shares were added through the exercise of stock acquisition rights, with dilution continuing to materialize as actual share issuance. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 906,000 27,948,400 267,195 2,407,028 266,385 2,310,218 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 906,000 shares were added through the exercise of stock acquisition rights, and capital and the capital reserve also increased. - FY2022MaterialisedAnnual report
「31 May 2021 2,950,000 26,990,800 823,050 2,131,366 823,050 2,035,366 1 April 2021–31 March 2022 51,600 27,042,400 8,467 2,139,833 8,467 2,043,833」
In addition to the issuance of 2,950,000 shares through a third-party allotment, 51,600 shares were added through the exercise of stock acquisition rights, and dilution progressed as actual share issuance. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 2,200 27,041,000 291 2,139,648 291 2,043,648 (Note) Between 1 October 2021 and 31 December 2021, the exercise of stock acquisition rights increased the total number of shares issued and outstanding by 2,200 shares and increased capital and the capital reserve by ¥291 thousand each.」
During the third quarter, 2,200 shares were added through the exercise of stock acquisition rights, with dilution continuing to materialize as actual share issuance. - FY2022-Q1MaterialisedAnnual report
「At a meeting of the Board of Directors held on 14 May 2021, the Company resolved to issue new shares allocated to a third party, as well as the 2021 First Series Stock Acquisition Rights and 2021 Second Series Stock Acquisition Rights,」
The issuance of new shares and stock acquisition rights through a third-party allotment was approved and payment completed, resulting in an increase in the number of shares issued and outstanding. - FY2021-Q3MaterialisedAnnual report
「1 October 2020–31 December 2020 (Note) 8,000 24,023,000 1,060 1,305,957 1,060 1,209,957 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, 8,000 shares were added through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2021-Q2MaterialisedAnnual report
「1 July 2020–30 September 2020 (Note) 29,200 24,015,000 3,869 1,304,897 3,869 1,208,897 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 29,200 shares were added through the exercise of stock acquisition rights, and dilution through share issuance continued. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 (Note) 52,600 23,985,800 6,969 1,301,028 6,969 1,205,028 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 52,600 shares were added through the exercise of stock acquisition rights, and dilution through share issuance continued. - FY2020MaterialisedAnnual report
「1 April 2019–31 March 2020 239,700 shares Increase due to the exercise of stock acquisition rights (stock options)」
During the fiscal year, 239,700 shares were added through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2020-Q3MaterialisedAnnual report
「1 October 2019–31 December 2019 (Note) 33,600 23,838,800 1,572 1,281,551 1,572 1,185,551 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, 33,600 shares were added through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2020-Q2MaterialisedAnnual report
「1 July 2019–30 September 2019 (Note) 47,400 23,805,200 5,800 1,279,979 5,800 1,183,979 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 47,400 shares were added through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2020-Q1MaterialisedAnnual report
「1 April 2019–30 June 2019 (Note) 64,300 23,757,800 7,403 1,274,178 7,403 1,178,178 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 64,300 shares were added through the exercise of stock acquisition rights, and dilution continued to materialize as actual share issuance. - FY2019MaterialisedAnnual report
「1 April 2018–31 March 2019 386,200 shares Increase due to the exercise of stock acquisition rights (stock options)」
During the fiscal year, 386,200 shares were added through the exercise of stock acquisition rights, and dilution continued to materialize as actual share issuance. - FY2019-Q3RestatedAnnual report
「1 October 2018–31 December 2018 (Note) 148,900 23,625,300 8,269 1,258,458 8,269 1,162,458 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter, 148,900 shares were added through the exercise of stock acquisition rights, and dilution through share issuance continued to materialize. - FY2019-Q2MaterialisedAnnual report
「1 July 2018–30 September 2018 (Note) 51,400 23,476,400 1,410 1,250,189 1,410 1,154,189 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 51,400 shares were issued through the exercise of stock acquisition rights, with dilution of share value continuing to materialize as actual share issuance. - FY2019-Q1MaterialisedAnnual report
「1 April 2018– 30 June 2018 (Note) 117,700 23,425,000 9,775 1,248,778 9,775 1,152,778 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 117,700 shares were issued through the exercise of stock acquisition rights, with dilution from potential shares continuing to materialize as actual share issuance. - FY2018-Q3MaterialisedAnnual report
「1 October 2017–31 December 2017 201,400 shares Increase due to the exercise of stock acquisition rights.」
During the third quarter, 201,400 shares were added through the exercise of stock acquisition rights, and dilution through share issuance continued to materialize. - FY2018-Q2MaterialisedAnnual report
「Change in total number of shares issued and outstanding 70,200 shares (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the second quarter, 70,200 shares were added through the exercise of stock acquisition rights, with dilution from potential shares becoming additional share issuance. - FY2018-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter, 69,500 shares were added through the exercise of stock acquisition rights, with dilution from potential shares becoming actual share issuance. - FY2017First statedAnnual report
「As of 31 March 2017, the number of potential shares arising from these stock acquisition rights was 967,000, equivalent to 8.59% of the total number of issued shares of 11,253,500.」
The disclosure states that the number of potential shares arising from stock options was 967,000, equivalent to 8.59% of total issued shares.